Skip to main content
Erschienen in: Diabetologia 11/2013

01.11.2013 | Article

Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts

Erschienen in: Diabetologia | Ausgabe 11/2013

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

The relationship between insulin secretion and the incidence of hypertension has not been well characterised. We hypothesised that both a parental history of diabetes and TCF7L2 rs7903146 polymorphism, which increases susceptibility to diabetes because of impaired beta cell function, are associated with incident hypertension. In a separate cohort, we assessed whether low insulin secretion is related to incident hypertension.

Methods

Nine year incident hypertension was studied in 2,391 normotensive participants from the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort. The relationship between insulin secretion and 3 year incident hypertension was investigated in 1,047 non-diabetic, normotensive individuals from the Relationship between Insulin Sensitivity and Cardiovascular Disease (RISC) cohort. Insulin secretion during OGTT was expressed in relation to the degree of insulin resistance, as assessed by a hyperinsulinaemic–euglycaemic clamp.

Results

In the DESIR cohort, a parental history of diabetes and the TCF7L2 at-risk variant were both associated with hypertension incidence at year 9, independently of waist circumference, BP, fasting glucose, insulin levels and HOMA-IR at inclusion (p = 0.02 for parental history, p = 0.006 for TCF7L2). In the RISC cohort, a lower insulin secretion rate during the OGTT at baseline was associated with both higher BP and a greater risk of hypertension at year 3. This inverse correlation between the insulin secretion rate and incident hypertension persisted after controlling for baseline insulin resistance, glycaemia and BP (p = 0.007).

Conclusions/interpretation

Parental history of diabetes, TCF7L2 rs7903146 polymorphism and a reduced insulin secretion rate were consistently associated with incident hypertension. A low insulin secretion rate might be a new risk factor for incident hypertension, beyond insulin resistance.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380:601–610PubMedCrossRef Ferrannini E, Cushman WC (2012) Diabetes and hypertension: the bad companions. Lancet 380:601–610PubMedCrossRef
2.
Zurück zum Zitat Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ (2007) Blood pressure and risk of developing type 2 diabetes mellitus: the Women’s Health Study. Eur Heart J 28:2937–2943PubMedCrossRef Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ (2007) Blood pressure and risk of developing type 2 diabetes mellitus: the Women’s Health Study. Eur Heart J 28:2937–2943PubMedCrossRef
3.
Zurück zum Zitat Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 342:905–912PubMedCrossRef Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL (2000) Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 342:905–912PubMedCrossRef
4.
Zurück zum Zitat Bjornholt JV, Erikssen G, Kjeldsen SE, Bodegard J, Thaulow E, Erikssen J (2003) Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure. J Hypertens 21:1383–1389PubMedCrossRef Bjornholt JV, Erikssen G, Kjeldsen SE, Bodegard J, Thaulow E, Erikssen J (2003) Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure. J Hypertens 21:1383–1389PubMedCrossRef
5.
Zurück zum Zitat He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK (1999) Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med 159:498–503PubMedCrossRef He J, Klag MJ, Caballero B, Appel LJ, Charleston J, Whelton PK (1999) Plasma insulin levels and incidence of hypertension in African Americans and whites. Arch Intern Med 159:498–503PubMedCrossRef
6.
Zurück zum Zitat Fagot-Campagna A, Balkau B, Simon D, Ducimetiere P, Eschwege E (1997) Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 26:542–550PubMedCrossRef Fagot-Campagna A, Balkau B, Simon D, Ducimetiere P, Eschwege E (1997) Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 26:542–550PubMedCrossRef
7.
Zurück zum Zitat Bower JK, Appel LJ, Matsushita K et al (2012) Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study. Diabetes Care 35:1031–1037PubMedCrossRef Bower JK, Appel LJ, Matsushita K et al (2012) Glycated hemoglobin and risk of hypertension in the atherosclerosis risk in communities study. Diabetes Care 35:1031–1037PubMedCrossRef
8.
Zurück zum Zitat Britton KA, Pradhan AD, Gaziano JM et al (2011) Hemoglobin A1c, body mass index, and the risk of hypertension in women. Am J Hypertens 24:328–334PubMedCrossRef Britton KA, Pradhan AD, Gaziano JM et al (2011) Hemoglobin A1c, body mass index, and the risk of hypertension in women. Am J Hypertens 24:328–334PubMedCrossRef
9.
Zurück zum Zitat Gloyn AL, Braun M, Rorsman P (2009) Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function. Diabetes 58:800–802PubMedCrossRef Gloyn AL, Braun M, Rorsman P (2009) Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function. Diabetes 58:800–802PubMedCrossRef
10.
Zurück zum Zitat Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250PubMedCrossRef Florez JC, Jablonski KA, Bayley N et al (2006) TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med 355:241–250PubMedCrossRef
11.
Zurück zum Zitat Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk): I. Methodology and objectives. Diabetologia 47:566–570PubMedCrossRef Hills SA, Balkau B, Coppack SW et al (2004) The EGIR-RISC STUDY (The European Group for the Study of Insulin Resistance: Relationship between Insulin Sensitivity and Cardiovascular Disease Risk): I. Methodology and objectives. Diabetologia 47:566–570PubMedCrossRef
12.
Zurück zum Zitat Gautier A, Roussel R, Lange C et al (2011) Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study. Diabetes 60:2654–2663PubMedCrossRef Gautier A, Roussel R, Lange C et al (2011) Effects of genetic susceptibility for type 2 diabetes on the evolution of glucose homeostasis traits before and after diabetes diagnosis: data from the D.E.S.I.R. Study. Diabetes 60:2654–2663PubMedCrossRef
13.
Zurück zum Zitat Bonnet F, Marre M, Halimi JM et al (2006) Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 24:1157–1163PubMedCrossRef Bonnet F, Marre M, Halimi JM et al (2006) Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 24:1157–1163PubMedCrossRef
14.
Zurück zum Zitat Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
15.
Zurück zum Zitat Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP (2011) How can we measure insulin sensitivity/resistance? Diabetes Metab 37:179–188PubMedCrossRef Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP (2011) How can we measure insulin sensitivity/resistance? Diabetes Metab 37:179–188PubMedCrossRef
16.
Zurück zum Zitat Bonnet F, Patel S, Laville M et al (2008) Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care 31:789–794PubMedCrossRef Bonnet F, Patel S, Laville M et al (2008) Influence of the ACE gene insertion/deletion polymorphism on insulin sensitivity and impaired glucose tolerance in healthy subjects. Diabetes Care 31:789–794PubMedCrossRef
17.
Zurück zum Zitat Bonnet F, Disse E, Laville M et al (2012) Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 55:3228–3237PubMedCrossRef Bonnet F, Disse E, Laville M et al (2012) Moderate alcohol consumption is associated with improved insulin sensitivity, reduced basal insulin secretion rate and lower fasting glucagon concentration in healthy women. Diabetologia 55:3228–3237PubMedCrossRef
18.
Zurück zum Zitat Craig CL, Marshall AL, Sjostrom M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395PubMedCrossRef Craig CL, Marshall AL, Sjostrom M et al (2003) International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35:1381–1395PubMedCrossRef
19.
Zurück zum Zitat Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMedCrossRef Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368–377PubMedCrossRef
20.
Zurück zum Zitat Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159–E1166PubMed
21.
Zurück zum Zitat Mari A, Tura A, Natali A et al (2010) Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia 53:749–756PubMedCrossRef Mari A, Tura A, Natali A et al (2010) Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia 53:749–756PubMedCrossRef
22.
Zurück zum Zitat O’Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225–1230PubMedCrossRef O’Rahilly S, Turner RC, Matthews DR (1988) Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225–1230PubMedCrossRef
23.
Zurück zum Zitat Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207PubMedCrossRef Meigs JB, Cupples LA, Wilson PW (2000) Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes 49:2201–2207PubMedCrossRef
24.
Zurück zum Zitat Bonadonna RC, Stumvoll M, Fritsche A et al (2003) Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52:470–480PubMedCrossRef Bonadonna RC, Stumvoll M, Fritsche A et al (2003) Altered homeostatic adaptation of first- and second-phase beta-cell secretion in the offspring of patients with type 2 diabetes: studies with a minimal model to assess beta-cell function. Diabetes 52:470–480PubMedCrossRef
25.
Zurück zum Zitat Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M (1998) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101:86–96PubMedCrossRef Vauhkonen I, Niskanen L, Vanninen E, Kainulainen S, Uusitupa M, Laakso M (1998) Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands. J Clin Invest 101:86–96PubMedCrossRef
26.
Zurück zum Zitat Frontoni S, Bracaglia D, Baroni A et al (2003) Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 41:1223–1227PubMedCrossRef Frontoni S, Bracaglia D, Baroni A et al (2003) Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 41:1223–1227PubMedCrossRef
27.
Zurück zum Zitat Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E (1989) Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 9:928–933PubMedCrossRef Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK, Ferrannini E (1989) Parental history of diabetes is associated with increased cardiovascular risk factors. Arteriosclerosis 9:928–933PubMedCrossRef
28.
Zurück zum Zitat Pontiroli AE, Monti LD, Pizzini A, Piatti P (2000) Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes. Diabetes Care 23:1359–1364PubMedCrossRef Pontiroli AE, Monti LD, Pizzini A, Piatti P (2000) Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes. Diabetes Care 23:1359–1364PubMedCrossRef
29.
Zurück zum Zitat Srinivasan SR, Frontini MG, Berenson GS (2003) Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa Heart Study. Metab Clin Exp 52:443–450, discussion 451–453PubMedCrossRef Srinivasan SR, Frontini MG, Berenson GS (2003) Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: the Bogalusa Heart Study. Metab Clin Exp 52:443–450, discussion 451–453PubMedCrossRef
30.
Zurück zum Zitat Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110PubMedCrossRef Florez JC (2008) Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes? Diabetologia 51:1100–1110PubMedCrossRef
31.
Zurück zum Zitat Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92:707–715PubMedCrossRef Drong AW, Lindgren CM, McCarthy MI (2012) The genetic and epigenetic basis of type 2 diabetes and obesity. Clin Pharmacol Ther 92:707–715PubMedCrossRef
32.
Zurück zum Zitat Cauchi S, Meyre D, Choquet H et al (2006) TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 55:3189–3192PubMedCrossRef Cauchi S, Meyre D, Choquet H et al (2006) TCF7L2 variation predicts hyperglycemia incidence in a French general population: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes 55:3189–3192PubMedCrossRef
33.
Zurück zum Zitat Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163PubMedCrossRef Lyssenko V, Lupi R, Marchetti P et al (2007) Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes. J Clin Invest 117:2155–2163PubMedCrossRef
34.
Zurück zum Zitat Villareal DT, Robertson H, Bell GI et al (2010) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 59:479–485PubMedCrossRef Villareal DT, Robertson H, Bell GI et al (2010) TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes 59:479–485PubMedCrossRef
35.
Zurück zum Zitat Yerram P, Whaley-Connell A (2012) Novel role for the incretins in blood pressure regulation. Curr Opin Nephrol Hypertens 21:463–468PubMedCrossRef Yerram P, Whaley-Connell A (2012) Novel role for the incretins in blood pressure regulation. Curr Opin Nephrol Hypertens 21:463–468PubMedCrossRef
36.
Zurück zum Zitat Gupta V, Khadgawat R, Ng HK et al (2012) Association of TCF7L2 and ADIPOQ with body mass index, waist-hip ratio, and systolic blood pressure in an endogamous ethnic group of India. Genet Test Mol Biomark 16:948–951CrossRef Gupta V, Khadgawat R, Ng HK et al (2012) Association of TCF7L2 and ADIPOQ with body mass index, waist-hip ratio, and systolic blood pressure in an endogamous ethnic group of India. Genet Test Mol Biomark 16:948–951CrossRef
37.
Zurück zum Zitat Ehret GB, Munroe PB, Rice KM et al (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:103–109PubMedCrossRef Ehret GB, Munroe PB, Rice KM et al (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478:103–109PubMedCrossRef
38.
Zurück zum Zitat Arnlov J, Pencina MJ, Nam BH et al (2005) Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation 112:1719–1727PubMedCrossRef Arnlov J, Pencina MJ, Nam BH et al (2005) Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation 112:1719–1727PubMedCrossRef
39.
Zurück zum Zitat Liese AD, Mayer-Davis EJ, Chambless LE et al (1999) Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis Risk in Communities Study Investigators. J Hypertens 17:1169–1177PubMedCrossRef Liese AD, Mayer-Davis EJ, Chambless LE et al (1999) Elevated fasting insulin predicts incident hypertension: the ARIC study. Atherosclerosis Risk in Communities Study Investigators. J Hypertens 17:1169–1177PubMedCrossRef
40.
Zurück zum Zitat Xun P, Liu K, Cao W, Sidney S, Williams OD, He K (2012) Fasting insulin level is positively associated with incidence of hypertension among American young adults: a 20-year follow-up study. Diabetes Care 35:1532–1537PubMedCrossRef Xun P, Liu K, Cao W, Sidney S, Williams OD, He K (2012) Fasting insulin level is positively associated with incidence of hypertension among American young adults: a 20-year follow-up study. Diabetes Care 35:1532–1537PubMedCrossRef
41.
Zurück zum Zitat Baron AD (1994) Hemodynamic actions of insulin. Am J Physiol 267:E187–E202PubMed Baron AD (1994) Hemodynamic actions of insulin. Am J Physiol 267:E187–E202PubMed
42.
Zurück zum Zitat Heise T, Magnusson K, Heinemann L, Sawicki PT (1998) Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 32:243–248PubMedCrossRef Heise T, Magnusson K, Heinemann L, Sawicki PT (1998) Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension 32:243–248PubMedCrossRef
43.
Zurück zum Zitat Rask-Madsen C, Li Q, Freund B et al (2010) Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 11:379–389PubMedCrossRef Rask-Madsen C, Li Q, Freund B et al (2010) Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 11:379–389PubMedCrossRef
44.
Zurück zum Zitat Galkina EV, Butcher M, Keller SR et al (2012) Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1. Arterioscler Thromb Vasc Biol 32:247–256PubMedCrossRef Galkina EV, Butcher M, Keller SR et al (2012) Accelerated atherosclerosis in Apoe-/- mice heterozygous for the insulin receptor and the insulin receptor substrate-1. Arterioscler Thromb Vasc Biol 32:247–256PubMedCrossRef
45.
Zurück zum Zitat Mistry GC, Maes AL, Lasseter KC et al (2008) Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol 48:592–598PubMedCrossRef Mistry GC, Maes AL, Lasseter KC et al (2008) Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood pressure in nondiabetic patients with mild to moderate hypertension. J Clin Pharmacol 48:592–598PubMedCrossRef
46.
Zurück zum Zitat Koren S, Shemesh-Bar L, Tirosh A et al (2012) The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in type 2 diabetes mellitus patients. Diabetes Technol Ther 14:561–567PubMedCrossRef Koren S, Shemesh-Bar L, Tirosh A et al (2012) The effect of sitagliptin versus glibenclamide on arterial stiffness, blood pressure, lipids, and inflammation in type 2 diabetes mellitus patients. Diabetes Technol Ther 14:561–567PubMedCrossRef
47.
Zurück zum Zitat Cherney DZ, Scholey JW, Sochett E, Bradley TJ, Reich HN (2011) The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care 34:177–180PubMedCrossRef Cherney DZ, Scholey JW, Sochett E, Bradley TJ, Reich HN (2011) The acute effect of clamped hyperglycemia on the urinary excretion of inflammatory cytokines/chemokines in uncomplicated type 1 diabetes: a pilot study. Diabetes Care 34:177–180PubMedCrossRef
48.
Zurück zum Zitat Monnier L, Mas E, Ginet C et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687PubMedCrossRef Monnier L, Mas E, Ginet C et al (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295:1681–1687PubMedCrossRef
49.
Zurück zum Zitat Di Flaviani A, Picconi F, Di Stefano P et al (2011) Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 34:1605–1609PubMedCrossRef Di Flaviani A, Picconi F, Di Stefano P et al (2011) Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care 34:1605–1609PubMedCrossRef
50.
Zurück zum Zitat Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486–494PubMedCrossRef Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290:486–494PubMedCrossRef
Metadaten
Titel
Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts
Publikationsdatum
01.11.2013
Erschienen in
Diabetologia / Ausgabe 11/2013
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3021-y

Weitere Artikel der Ausgabe 11/2013

Diabetologia 11/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.